Anti-EFCAB2 monoclonal antibody

Pre-made anti-EFCAB2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to EFCAB2/EFCAB2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2468-Ab-1/ GM-Tg-hg-IP2468-Ab-2Anti-Human EFCAB2 monoclonal antibodyHuman
GM-Tg-rg-IP2468-Ab-1/ GM-Tg-rg-IP2468-Ab-2Anti-Rat EFCAB2 monoclonal antibodyRat
GM-Tg-mg-IP2468-Ab-1/ GM-Tg-mg-IP2468-Ab-2Anti-Mouse EFCAB2 monoclonal antibodyMouse
GM-Tg-cynog-IP2468-Ab-1/ GM-Tg-cynog-IP2468-Ab-2Anti-Cynomolgus/ Rhesus macaque EFCAB2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2468-Ab-1/ GM-Tg-felg-IP2468-Ab-2Anti-Feline EFCAB2 monoclonal antibodyFeline
GM-Tg-cang-IP2468-Ab-1/ GM-Tg-cang-IP2468-Ab-2Anti-Canine EFCAB2 monoclonal antibodyCanine
GM-Tg-bovg-IP2468-Ab-1/ GM-Tg-bovg-IP2468-Ab-2Anti-Bovine EFCAB2 monoclonal antibodyBovine
GM-Tg-equg-IP2468-Ab-1/ GM-Tg-equg-IP2468-Ab-2Anti-Equine EFCAB2 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2468-Ab-1/ GM-Tg-hg-IP2468-Ab-2; GM-Tg-rg-IP2468-Ab-1/ GM-Tg-rg-IP2468-Ab-2;
GM-Tg-mg-IP2468-Ab-1/ GM-Tg-mg-IP2468-Ab-2; GM-Tg-cynog-IP2468-Ab-1/ GM-Tg-cynog-IP2468-Ab-2;
GM-Tg-felg-IP2468-Ab-1/ GM-Tg-felg-IP2468-Ab-2; GM-Tg-cang-IP2468-Ab-1/ GM-Tg-cang-IP2468-Ab-2;
GM-Tg-bovg-IP2468-Ab-1/ GM-Tg-bovg-IP2468-Ab-2; GM-Tg-equg-IP2468-Ab-1/ GM-Tg-equg-IP2468-Ab-2
Products NameAnti-EFCAB2 monoclonal antibody
Formatmab
Target NameEFCAB2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-EFCAB2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2468-Ag-1Recombinant multi-species DRC8/ EFCAB2/ CFAP200 protein


    Target information

    Target IDGM-IP2468
    Target NameEFCAB2
    Gene ID84288,68226,289280,100428487,611783,101091334,615715,100065948
    Gene Symbol and Synonyms1700073K01Rik,CFAP200,D830011E08Rik,DRC8,EFCAB2,RGD1308593
    Uniprot AccessionQ5VUJ9
    Uniprot Entry NameDRC8_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000203666
    Target ClassificationN/A

    The target: EFCAB2, gene name: EFCAB2, also named as CFAP200, DRC8. The gene encodes a protein that contains two EF-hand calcium-binding domains although its function has yet to be determined. Alternatively spliced transcripts have been observed. [provided by RefSeq, Mar 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.